The University of Kansas Cancer Center reached a construction milestone on its new cancer research and clinical building with a topping out ceremony on Aug. 21. The project broke ground in May 2025. The project has been backed in part…
Oncology
Emerging research has linked GLP-1 medicines to a lower risk of breast cancer and better outcomes among people diagnosed with the disease. Here are five findings from studies highlighted in an Aug. 20 Breastcancer.org report: All of the studies were…
New York City-based Memorial Sloan Kettering Cancer Center reported operating income of $216.6 million (4.7% operating margin), up from an operating loss of $113.2 million (-2.7% margin) during the same period last year, according to its Aug. 14 financial report. …
Holyoke (Mass.) Medical Center is expanding its oncology and hematology services, adding two physicians and two new office locations to reach more cancer patients across the region. Masih Farooqui, MD, and Subramony Subramonia Iyer, MD, will join HMC’s medical staff…
The FDA has rejected a radiopharmaceutical therapy from ITM Isotope Technologies Munich that was positioned to compete with Novartis’ leading treatments in the space. The agency issued a complete response letter for ITM-11, also known as 177Lu-edotreotide, saying it cannot…
Advertisement
Irvine, Calif.-based UCI Health opened its 52-bed rehabilitation hospital, which will house the county’s first dedicated inpatient cancer rehab unit. The 68,000-square-foot freestanding UCI Health-Irvine Rehabilitation Hospital was developed through a joint venture partnership with Lifepoint Rehabilitation, according to an…
The FDA’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee will meet Sept. 23 to discuss and vote on Grail’s premarket approval application for its Galleri blood test, according to a notice published Aug. 10 in the…
The FDA has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg), a genetically modified oncolytic viral therapy for adults with unresectable advanced cutaneous melanoma whose disease progressed with a PD-1-blocking antibody-based regimen. Tudriqev is indicated in combination with nivolumab, according to…
The Human Cancer Models Initiative has developed 665 new cancer tissue models derived from patient tumors. The models cover 25 cancer types and were generated from 2,780 donors over a 10-year, NCI-funded effort, according to a study published in Nature. …
The American Association for Cancer Research Center for Cancer Clinical Trials enrolled its first patient in a phase 2 trial testing whether targeted drug regimens can let some stomach and esophageal cancer patients skip surgery. The trial, called AACR-ADOPT-GEA, is…